Stoke Therapeutics Inc (STOK)

EBITDA Growth

-182.03%

Quarterly · Period ending:

STOK logo

STOK EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-182.03%
STOK Quarterly EBITDA YoY % (-232.02% → -182.03%)
High-resolution chart · PNG

STOK ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Stoke Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-182.0289%
-140.2734%
-477.8023%
-49.2198%
8.3907%
544.1285%
62.1934%
-8.3037%
16.2966%
-17.6007%
-5.1425%
7.0676%
-23.3799%
10.0566%
-3.4403%
-15.1278%
-12.119%
-47.0797%
-68.7435%
-65.7862%
-69.8311%
-43.7446%
-31.2929%
-38.7093%
-53.3333%
-84.9087%
-144.6608%
-198.6781%
-181.092%
-232.0213%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.